Abstract The Bridge/El Puente program will serve 300 individuals being released from the
Hampden County Correctional Center (HCCC) to the county with a history of opiate and/or …

Medication-assisted treatment for drug-use disorders uses the US Food and Drug
Administration's (FDA's) approved medications of methadone, buprenorphine, or naltrexone …

Despite spending more than any other county on incarceration and reentry programs, the
United States continues to have some of the highest rates of reincarceration. Programs …

Buprenorphine is a medication that has been shown to “diminish the effects of physical
dependency to opioids (such as withdrawal symptoms and cravings), increase safety in …

Background: Justice-involved populations have high rates of opioid dependency and are at
most risk for overdose events, especially in the immediate post-release period. Excessive …

Despite spending more than any other county on incarceration and reentry programs, the
United States continues to have some of the highest rates of reincarceration. Programs …

The prevalence of opioid use disorders among people who are incarcerated is high. People
who are released from incarceration are at increased risk for overdose. The current study …

Last week, Mark Parrino, president of the American Association for the Treatment of Opioid
Dependence (AATOD), made the opening speech at the annual conference of the National …

Background Until recently, few carceral facilities offered medications for opioid use disorder
(MOUD). Although more facilities are adopting MOUD, much remains to be learned about …

Abstract The Rhode Island Department of Corrections (RIDOC) recently implemented the
first state-wide, comprehensive medications for addiction treatment (MAT) program in the …